Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

stepan co. - SCL

SCL

Close Chg Chg %
51.35 0.70 1.36%

Closed Market

52.05

+0.70 (1.36%)

Volume: 104.59K

Last Updated:

May 22, 2026, 3:59 PM EDT

Trade Now

Company Overview: stepan co. - SCL

SCL Key Data

Open

$51.71

 Day Range

51.46 - 52.09

52 Week Range

41.82 - 68.00

 Market Cap

$1.17B

Shares Outstanding

22.71M

 Public Float

21.59M

Beta

0.95

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.62

Yield

303.50%

 Dividend

$0.40

EX-DIVIDEND DATE

Jun 1, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

152.50K

  

SCL Performance

1 Week
 
 5.85%
 
1 Month
 
 0.02%
 
3 Months
 
 2.32%
 
1 Year
 
 -4.34%
 
5 Years
 
 -61.31%
 

SCL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About stepan co. - SCL

Stepan Co. engages in the manufacture and sale of specialty and intermediate chemicals. It operates through the following segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment products are used in consumer and industrial cleaning and disinfection products, agricultural products, lubricating ingredients, oil field chemicals, and other applications. The Polymers segment deals mainly with rigid foam for thermal insulation in the construction industry, plastics, building materials, refrigeration systems, and CASE applications. The Specialty Products segment consists of chemicals used in food, flavoring, nutritional supplements, and pharmaceutical applications. The company was founded by Alfred C. Stepan Jr. in 1932 and is headquartered in Northbrook, IL.

SCL At a Glance

Stepan Co.
1101 Skokie Boulevard
Northbrook, Illinois 60062
Phone 1-847-446-7500 Revenue 2.33B
Industry Chemicals: Specialty Net Income 46.90M
Sector Process Industries 2025 Sales Growth 6.964%
Fiscal Year-end 12 / 2026 Employees 2,328
View SEC Filings

SCL Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 23.117
Price to Sales Ratio 0.465
Price to Book Ratio 0.861
Price to Cash Flow Ratio 7.33
Enterprise Value to EBITDA 8.426
Enterprise Value to Sales 0.704
Total Debt to Enterprise Value 0.421

SCL Efficiency

Revenue/Employee 1,001,767.182
Income Per Employee 20,143.90
Receivables Turnover 6.011
Total Asset Turnover 1.00

SCL Liquidity

Current Ratio 1.289
Quick Ratio 0.84
Cash Ratio 0.199

SCL Profitability

Gross Margin 11.572
Operating Margin 2.954
Pretax Margin 2.569
Net Margin 2.011
Return on Assets 2.012
Return on Equity 3.885
Return on Total Capital 2.423
Return on Invested Capital 2.936

SCL Capital Structure

Total Debt to Total Equity 55.55
Total Debt to Total Capital 35.712
Total Debt to Total Assets 29.31
Long-Term Debt to Equity 31.376
Long-Term Debt to Total Capital 20.171
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Stepan Co. - SCL

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
2.77B 2.33B 2.18B 2.33B
Sales Growth
+18.21% -16.14% -6.26% +6.96%
Cost of Goods Sold (COGS) incl D&A
2.35B 2.05B 1.91B 2.06B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
94.65M 105.34M 112.20M 126.04M
Depreciation
87.81M 97.97M 105.28M 119.49M
Amortization of Intangibles
6.83M 7.37M 6.91M 6.55M
COGS Growth
+20.31% -12.70% -6.84% +8.08%
Gross Income
427.06M 277.59M 272.20M 269.88M
Gross Income Growth
+7.90% -35.00% -1.94% -0.85%
Gross Profit Margin
+15.40% +11.94% +12.48% +11.57%
2022 2023 2024 2025 5-year trend
SG&A Expense
218.45M 204.98M 194.93M 200.99M
Research & Development
66.63M 59.04M 55.67M 59.28M
Other SG&A
151.81M 145.94M 139.26M 141.71M
SGA Growth
-1.46% -6.17% -4.90% +3.11%
Other Operating Expense
- - - -
-
Unusual Expense
1.29M 14.01M 6.80M 6.25M
EBIT after Unusual Expense
207.33M 58.60M 70.47M 62.64M
Non Operating Income/Expense
(7.74M) 5.73M 9.43M 23.49M
Non-Operating Interest Income
2.84M 4.70M 6.58M 5.04M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
10.89M 15.95M 19.46M 26.23M
Interest Expense Growth
+55.38% +46.44% +22.07% +34.75%
Gross Interest Expense
17.85M 29.36M 33.03M 30.77M
Interest Capitalized
6.96M 13.41M 13.56M 4.54M
Pretax Income
188.70M 48.39M 60.44M 59.90M
Pretax Income Growth
+9.37% -74.36% +24.90% -0.89%
Pretax Margin
+6.80% +2.08% +2.77% +2.57%
Income Tax
41.55M 8.19M 10.07M 13.01M
Income Tax - Current - Domestic
49.20M (23.40M) 1.70M (3.10M)
Income Tax - Current - Foreign
19.80M 13.29M 18.66M 17.50M
Income Tax - Deferred - Domestic
(27.58M) 20.71M (6.34M) (1.82M)
Income Tax - Deferred - Foreign
127.00K (2.41M) (3.95M) 430.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
147.15M 40.20M 50.37M 46.90M
Minority Interest Expense
- - - -
-
Net Income
147.15M 40.20M 50.37M 46.90M
Net Income Growth
+6.78% -72.68% +25.29% -6.90%
Net Margin Growth
+5.31% +1.73% +2.31% +2.01%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
147.15M 40.20M 50.37M 46.90M
Preferred Dividends
- - - -
-
Net Income Available to Common
147.15M 40.20M 50.37M 46.90M
EPS (Basic)
6.4595 1.7651 2.2061 2.0503
EPS (Basic) Growth
+7.45% -72.67% +24.98% -7.06%
Basic Shares Outstanding
22.78M 22.78M 22.83M 22.87M
EPS (Diluted)
6.3802 1.7521 2.1966 2.0487
EPS (Diluted) Growth
+7.82% -72.54% +25.37% -6.73%
Diluted Shares Outstanding
23.06M 22.95M 22.93M 22.89M
EBITDA
303.26M 177.95M 189.47M 194.93M
EBITDA Growth
+14.44% -41.32% +6.47% +2.88%
EBITDA Margin
+10.94% +7.65% +8.69% +8.36%

Snapshot

Average Recommendation BUY Average Target Price 85.00
Number of Ratings 1 Current Quarters Estimate 0.61
FY Report Date 06 / 2026 Current Year's Estimate 2.535
Last Quarter’s Earnings 0.45 Median PE on CY Estimate N/A
Year Ago Earnings 1.82 Next Fiscal Year Estimate 3.915
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 2
Mean Estimate 0.61 0.93 2.54 3.92
High Estimates 0.64 0.98 2.72 3.92
Low Estimate 0.58 0.88 2.35 3.91
Coefficient of Variance 6.96 7.60 10.32 0.18

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Stepan Co. - SCL

Date Name Shares Transaction Value
May 6, 2026 Robert J. Haire EVP, Supply Chain 4,510 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $50.33 per share 226,988.30
May 6, 2026 Robert J. Haire EVP, Supply Chain N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 6, 2026 Robert J. Haire EVP, Supply Chain 3,960 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $50.33 per share 199,306.80
Apr 16, 2026 Robin Joseph Weitkamp VP and GM Surfactants-INT 1,429 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 16, 2026 Robin Joseph Weitkamp VP and GM Surfactants-INT 2,859 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 16, 2026 Robin Joseph Weitkamp VP and GM Surfactants-INT 4,030 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 16, 2026 Afonso Adriano Jose Galimberti VP and GM Surfactants NA 2,621 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 16, 2026 Afonso Adriano Jose Galimberti VP and GM Surfactants NA 1,310 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 16, 2026 Afonso Adriano Jose Galimberti VP and GM Surfactants NA 3,694 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Sean T. Moriarty VP & GM Surfactants 14,303 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $66.39 per share 949,576.17
Feb 20, 2026 Richard Finn Stepan V.P. and Gen l. Mgr., Polymers N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 20, 2026 Richard Finn Stepan V.P. and Gen l. Mgr., Polymers 241,339 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $66.39 per share 16,022,496.21
Feb 20, 2026 Richard Finn Stepan V.P. and Gen l. Mgr., Polymers 241,457 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $66.39 per share 16,030,330.23
Feb 20, 2026 Luis E. Rojo President & CEO; Director 15,641 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $66.39 per share 1,038,405.99
Feb 20, 2026 Luis E. Rojo President & CEO; Director 15,878 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $66.39 per share 1,054,140.42
Feb 20, 2026 Sean T. Moriarty VP & GM Surfactants N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 20, 2026 Sean T. Moriarty VP & GM Surfactants 14,145 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $66.39 per share 939,086.55
Feb 20, 2026 F. Quinn Stepan Director 78,398 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 F. Quinn Stepan Director N/A Bona fide gift 0.00
Feb 20, 2026 F. Quinn Stepan Director N/A Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.32 per share 0.00

Stepan Co. in the News